Retraction
MiR-144 Suppresses Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Targeting SMAD4
Paper Information
Record ID:
29034
Author(s):
Journal:
Publication Date:
July 29, 2016
Retraction Date:
May 19, 2021
(4.5 years years ago)
Subjects:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Taylor and Francis - Dove Press
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.2147/OTT.S319073Additional Notes:
see also: https://pubpeer.com/publications/180F23C68669E5FF8CBF2F23BE4A08
Citations (34)
34
Total Citations7
Post-Retraction(20.6%)
27
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
5
Within 1 year
2
After 2+ years
957
Days since retraction (latest)
The Role of TGF-β/SMAD Signaling in Hepatocellular Carcinoma: from Mechanism to Therapy and Prognosis
Xin Xin, Xiyu Cheng, Fanxin Zeng et al. (5 authors)
International Journal of Biological Sciences
Open Access
Published: Jan 2024
35 citations
35 citations
957 days after retraction
Multi-View Enhanced Tensor Nuclear Norm and Local Constraint Model for Cancer Clustering and Feature Gene Selection
Qian Qiao, Shasha Yuan, Junliang Shang et al. (4 authors)
Journal of Computational Biology
Published: Jul 2023
1 citation
1 citation
792 days after retraction
miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers
Hesham A. El-Mahdy, Al-Aliaa M. Sallam, Ahmed Ismail et al. (6 authors)
Pathology - Research and Practice
Published: Apr 2022
60 citations
60 citations
321 days after retraction
MicroRNA‐144‐3p controls the apoptosis of pulmonary artery endothelial cells in pulmonary arterial hypertension via the BMPR2/Smad4 signaling pathway
Chao Shi, Xiaolei Liu, Jalil Ur Rahman et al. (5 authors)
Clinical and Translational Discovery
Open Access
Published: Jan 2022
2 citations
2 citations
244 days after retraction
TOP2A promotes proliferation and metastasis of hepatocellular carcinoma regulated by miR-144-3p
Tao Wang, Jing Lu, Rangrang Wang et al. (5 authors)
Journal of Cancer
Open Access
Published: Jan 2022
46 citations
46 citations
227 days after retraction
A Tensor Robust Model Based on Enhanced Tensor Nuclear Norm and Low-Rank Constraint for Multi-view Cancer Genomics Data
Qian Qiao, Shasha Yuan, Junliang Shang et al. (4 authors)
Lecture notes in computer science
Published: Jan 2022
227 days after retraction
Prognostic prediction and gene regulation network of EIF2S2 in hepatocellular carcinoma based on data mining
Piyou Ji, Haitao Wang, Yu Cheng et al. (4 authors)
Journal of Gastrointestinal Oncology
Open Access
Published: Dec 2021
14 citations
14 citations
196 days after retraction
MiR-144-3p inhibits the proliferation, migration and invasion of lung adenocargen cancer cells by targeting COL11A1
Yahong Sun, Zhihao Liu, Lifei Huang et al. (4 authors)
Journal of Chemotherapy
Published: Apr 2021
10 citations
10 citations
36 days before retraction
MicroRNA-362 negatively and positively regulates SMAD4 expression in TGF-β/SMAD signaling to suppress cell migration and invasion
Han Ping Cheng, Chiu-Jung Huang, Ming‐Long Tsai et al. (7 authors)
International Journal of Medical Sciences
Open Access
Published: Jan 2021
7 citations
7 citations
138 days before retraction
The combination of coffee compounds attenuates early fibrosis-associated hepatocarcinogenesis in mice: involvement of miRNA profile modulation
Guilherme Ribeiro Romualdo, Gabriel Bacil Prata, Tereza Cristina da Silva et al. (9 authors)
The Journal of Nutritional Biochemistry
Open Access
Published: Aug 2020
19 citations
19 citations
280 days before retraction
miR‑144‑3p inhibits tumor cell growth and invasion in oral squamous cell carcinoma through the downregulation of the oncogenic gene, EZH2
Longlong He, Lifan Liao, Liangzhi Du
International Journal of Molecular Medicine
Open Access
Published: Jun 2020
18 citations
18 citations
342 days before retraction
Potential Onco-Suppressive Role of miR122 and miR144 in Uveal Melanoma through ADAM10 and C-Met Inhibition
Adriana Amaro, Michela Croce, Silvano Ferrini et al. (14 authors)
Cancers
Open Access
Published: Jun 2020
17 citations
17 citations
349 days before retraction
The Underlying Mechanisms of Noncoding RNAs in the Chemoresistance of Hepatocellular Carcinoma
Man Wang, Fei Yu, Xinzhe Chen et al. (5 authors)
Molecular Therapy — Nucleic Acids
Open Access
Published: May 2020
44 citations
44 citations
369 days before retraction
MiR-144: A New Possible Therapeutic Target and Diagnostic/Prognostic Tool in Cancers
Omid Kooshkaki, Zohre Rezaei, Meysam Rahmati et al. (10 authors)
International Journal of Molecular Sciences
Open Access
Published: Apr 2020
54 citations
54 citations
406 days before retraction
MicroRNA-144: A novel biological marker and potential therapeutic target in human solid cancers
Meng Zhou, Yuncui Wu, Li Hongwu et al. (4 authors)
Journal of Cancer
Open Access
Published: Jan 2020
17 citations
17 citations
504 days before retraction
MicroRNA-144-3p Inhibits Tumorigenesis of Oral Squamous Cell Carcinoma by downregulating ERO1L
Xian Li, Yong Li, Chao Jiang et al. (5 authors)
Journal of Cancer
Open Access
Published: Dec 2019
22 citations
22 citations
523 days before retraction
MicroRNAs in Animal Models of HCC
Francesca Fornari, Laura Gramantieri, Elisa Callegari et al. (7 authors)
Cancers
Open Access
Published: Dec 2019
35 citations
35 citations
535 days before retraction
Tissue-based miRNA mapping in alcoholic liver cirrhosis: different profiles in cirrhosis with or without hepatocellular carcinoma
Philipp Felgendreff, Nathanael Raschzok, Kerstin E. Kunze et al. (13 authors)
Biomarkers
Published: Nov 2019
7 citations
7 citations
558 days before retraction
MicroRNA-144 inhibits cell proliferation, migration and invasion in human hepatocellular carcinoma by targeting CCNB1
Junsheng Gu, Xiaorui Liu, Juan Li et al. (4 authors)
Cancer Cell International
Open Access
Published: Jan 2019
96 citations
96 citations
856 days before retraction
Identifying miRNA-mRNA Pairs and Novel miRNAs from Hepatocelluar Carcinoma miRNomes and TCGA Database
Ping Wu, Yunyue Xiao, Tao Guo et al. (7 authors)
Journal of Cancer
Open Access
Published: Jan 2019
24 citations
24 citations
869 days before retraction
AZD3759 induces apoptosis in hepatoma cells by activating a p53-SMAD4 positive feedback loop
Danyang Chao, Lijun Pang, Ying Shi et al. (5 authors)
Biochemical and Biophysical Research Communications
Published: Dec 2018
7 citations
7 citations
873 days before retraction
Loss of miR-144 signaling interrupts extracellular matrix remodeling after myocardial infarction leading to worsened cardiac function
Quan He, Fangfei Wang, Takashi Honda et al. (6 authors)
Scientific Reports
Open Access
Published: Nov 2018
29 citations
29 citations
922 days before retraction
MicroRNA-18a promotes hepatocellular carcinoma proliferation, migration, and invasion by targeting Bcl2L10
Xiaodong Wang, Jian Lu, Jisen Cao et al. (6 authors)
OncoTargets and Therapy
Open Access
Published: Nov 2018
23 citations
23 citations
930 days before retraction
Extracellular Vesicle-Associated mir-21 and mir-144 Are Markedly Elevated in Serum of Patients With Hepatocellular Carcinoma
Chunwen Pu, Hui Huang, Zhidong Wang et al. (10 authors)
Frontiers in Physiology
Open Access
Published: Jul 2018
58 citations
58 citations
1037 days before retraction
LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma
Jun Lv, Yongkui Kong, Zhiqiang Gao et al. (6 authors)
The International Journal of Biochemistry & Cell Biology
Published: May 2018
79 citations
79 citations
1095 days before retraction
Effects of miR-144 on the sensitivity of human anaplastic thyroid carcinoma cells to cisplatin by autophagy regulation
Jing Liu, Liguo Feng, Haitao Zhang et al. (9 authors)
Cancer Biology & Therapy
Open Access
Published: Mar 2018
27 citations
27 citations
1171 days before retraction
miR144-3p inhibits PMVECs excessive proliferation in angiogenesis of hepatopulmonary syndrome via Tie2
Congwen Yang, Keyi Lv, Bin Chen et al. (9 authors)
Experimental Cell Research
Open Access
Published: Feb 2018
14 citations
14 citations
1189 days before retraction
Intravenous miR-144 inhibits tumor growth in diethylnitrosamine-induced hepatocellular carcinoma in mice
Quan He, Fangfei Wang, Takashi Honda et al. (7 authors)
Tumor Biology
Open Access
Published: Oct 2017
15 citations
15 citations
1326 days before retraction
Targeting epithelial–mesenchymal plasticity in cancer: clinical and preclinical advances in therapy and monitoring
Sugandha Bhatia, James Monkman, Alan Kie Leong Toh et al. (5 authors)
Biochemical Journal
Published: Sep 2017
63 citations
63 citations
1337 days before retraction
A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma
Hai‐Wei Liang, Zhihua Ye, Shuya Yin et al. (10 authors)
OncoTargets and Therapy
Open Access
Published: Jul 2017
28 citations
28 citations
1418 days before retraction
miRNAs in nutrition, obesity, and cancer: The biology of miRNAs in metabolic disorders and its relationship with cancer development
Verónica Martínez-Jiménez, Alejandro Méndez‐Mancilla, Diana Patricia Portales‐Pérez
Molecular Nutrition & Food Research
Published: Jun 2017
19 citations
19 citations
1441 days before retraction
Search for useful biomarkers in hepatocellular carcinoma, tumor factors and background liver factors
Dai Shimizu, Yoshikuni Inokawa, Fuminori Sonohara et al. (5 authors)
Oncology Reports
Open Access
Published: Mar 2017
12 citations
12 citations
1510 days before retraction
MiR-34a-3p alters proliferation and apoptosis of meningioma cells in vitro and is directly targeting SMAD4, FRAT1 and BCL2
Tamara V. Werner, Martin Hart, Ruth M. Nickels et al. (9 authors)
Aging
Open Access
Published: Mar 2017
48 citations
48 citations
1518 days before retraction
Over-expression of Thrombospondin 4 correlates with loss of miR-142 and contributes to migration and vascular invasion of advanced hepatocellular carcinoma
Fang Su, Jun Zhao, Shukui Qin et al. (19 authors)
Oncotarget
Open Access
Published: Feb 2017
42 citations
42 citations
1566 days before retraction
Quick Stats
Total Citations:
34
Years Since Retraction:
4.5 years
Open Access:
Yes
Last Checked:
Jul 24, 2025